“I’m absolutely delighted today that we’re on the verge of having a work programme.”
By Anna Barrett, Alabama Reflector
The Alabama Medical Cannabis Board on Thursday approved three dispensary licenses in what board members called a critical step. making medical cannabis available in Alabama Almost five years after the legislature enacted the program.
“We’ve waited a long time to get to this point where we can make a decision like this, and it’s monumental,” said board chairman Rex Vaughn. “It’s a milestone for us, so I’m excited we can get this far.”
GP6 Wellness, RJK Holdings and CCS will receive Alabama dispensary licenses within 28 days, as long as the companies pay a $40,000 licensing fee. A fourth license will be approved by the board in late January based on a recommendation from an administrative law judge, Vaughn said after the meeting.
Vaughn said several times at the meeting that the approval of the dispensary licenses is a milestone and will provide the care patients need and tax revenue for the state.
“It takes time to get through the system, but we should be seeing revenue by spring at the latest,” Vaughn said.
Alabama’s cannabis law, passed in 2021, allows registered doctors to prescribe cannabis for about 15 medical conditions, including cancer, depression, Parkinson’s disease, PTSD, sickle cell anemia, chronic pain and terminal illnesses. Acceptable product forms are limited to tablets, tinctures, patches, oils, and gummies (peach flavor only), herbal raw materials and smoking forms are prohibited.
People suffering from the conditions must obtain a doctor’s authorization and enter the patient registry to purchase products at a pharmacy.
Lawsuits have also hindered access to medical cannabis. Some companies sued the commission for not issuing licenses, citing a discriminatory process. In another case there were five Parents sued the board over delays in accessing cannabiswhich was released in August.
As of Thursday, the commission has issued licenses to nine growers, four processors, four transporters and three dispensaries. There is also a patient on the registry, Vaughn said.
Vaughn could not provide a specific timeline for when the product will be available for purchase, but estimated spring 2026. Earlier this year, AMCC Executive Director John McMillan expressed hope to have medical cannabis available to patients by the end of 2025.
“We need to get our medical certified quickly. All of those things are being arranged as we speak right now, and we’ll see how the winter goes,” Vaughn said. “Hopefully all these things will be implemented fairly quickly.”
Sam Blakemore, a pharmacist and board member, said in an interview after the meeting that medical cannabis can help relieve symptoms without side effects such as nausea and vomiting.
“Everyone focuses on Delta-9, but there are over 120 chemicals in the plant that are able to provide this whole-body experience to allow patients to really get relief when they have nausea and vomiting and spasticity,” Blakemore said.
Blakemore primarily prescribes drugs for pediatric oncology patients. He brought his wife and two young children to the meeting to celebrate the approval of the licenses.
“I’m not going to say that cannabis is a cure, but the most important thing to get that right now is at least people, I call patients and in the state where I close them, they can get relief,” Blakemore said. “They can’t get relief from opioids. They can’t get relief from gabapentin. They might finally be able to try something.”
Supporters of medicinal cannabis attended the meeting on Thursday.
Amanda Taylor, a medical cannabis patient advocate, has been part of the commission’s process since 2021. He has multiple brain and spinal injuries.
“I am very happy today because we are on the point of having a work program,” he said in an interview after the meeting.
This story was first published by the Alabama Reflector.